Literature DB >> 20833739

Fertility and pregnancy outcomes following conservative treatment for placenta accreta.

Loïc Sentilhes1, Gilles Kayem, Clémence Ambroselli, Magali Provansal, Hervé Fernandez, Franck Perrotin, Norbert Winer, Fabrice Pierre, Alexandra Benachi, Michel Dreyfus, Estelle Bauville, Dominique Mahieu-Caputo, Loïc Marpeau, Philippe Descamps, Florence Bretelle, François Goffinet.   

Abstract

BACKGROUND: The aim of this study was to estimate the fertility and pregnancy outcomes after successful conservative treatment for placenta accreta.
METHODS: This retrospective national multicenter study included women with a history of conservative management for placenta accreta in French university hospitals from 1993 through 2007. Success of conservative treatment was defined by uterine preservation. Data were retrieved from medical files and telephone interviews.
RESULTS: Follow-up data were available for 96 (73.3%) of the 131 women included in the study. There were eight women who had severe intrauterine synechiae and were amenorrheic. Of the 27 women who wanted more children, 3 women were attempting to become pregnant (mean duration: 11.7 months, range: 7-14 months), and 24 (88.9% [95% confidence interval (CI), 70.8-97.6%]) women had had 34 pregnancies (21 third-trimester deliveries, 1 ectopic pregnancy, 2 elective abortions and 10 miscarriages) with a mean time to conception of 17.3 months (range, 2-48 months). All 21 deliveries had resulted in healthy babies born after 34 weeks of gestation. Placenta accreta recurred in 6 of 21 cases [28.6% (95% CI, 11.3-52.2%)] and was associated with placenta previa in 4 cases. Post-partum hemorrhage occurred in four [19.0% (95% CI, 5.4-41.9%)] cases, related to placenta accreta in three and to uterine atony in one.
CONCLUSIONS: Successful conservative treatment for placenta accreta does not appear to compromise the patients' subsequent fertility or obstetrical outcome. Nevertheless, patients should be advised of the high risk that placenta accreta may recur during future pregnancies.

Entities:  

Mesh:

Year:  2010        PMID: 20833739      PMCID: PMC3413618          DOI: 10.1093/humrep/deq239

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  19 in total

1.  Maternal outcome after conservative treatment of placenta accreta.

Authors:  Loïc Sentilhes; Clémence Ambroselli; Gilles Kayem; Magali Provansal; Hervé Fernandez; Franck Perrotin; Norbert Winer; Fabrice Pierre; Alexandra Benachi; Michel Dreyfus; Estelle Bauville; Dominique Mahieu-Caputo; Loïc Marpeau; Philippe Descamps; François Goffinet; Florence Bretelle
Journal:  Obstet Gynecol       Date:  2010-03       Impact factor: 7.661

2.  Emergency obstetric hysterectomy.

Authors:  George Daskalakis; Eleftherios Anastasakis; Nikolaos Papantoniou; Spyros Mesogitis; Mariana Theodora; Aris Antsaklis
Journal:  Acta Obstet Gynecol Scand       Date:  2007       Impact factor: 3.636

3.  Expression of epidermal growth factor receptor and c-erbB-2 oncoprotein in trophoblast populations of placenta accreta.

Authors:  Jenn J Tseng; Shih L Hsu; Mei C Wen; Esther Shih C Ho; Min M Chou
Journal:  Am J Obstet Gynecol       Date:  2004-12       Impact factor: 8.661

4.  Abnormal placentation: twenty-year analysis.

Authors:  Serena Wu; Masha Kocherginsky; Judith U Hibbard
Journal:  Am J Obstet Gynecol       Date:  2005-05       Impact factor: 8.661

5.  Management of placenta accreta: morbidity and outcome.

Authors:  Florence Bretelle; Blandine Courbière; Chafika Mazouni; Aubert Agostini; Ludovic Cravello; Léon Boubli; Marc Gamerre; Claude D'Ercole
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2006-09-11       Impact factor: 2.435

6.  Clinical risk factors for placenta previa-placenta accreta.

Authors:  D A Miller; J A Chollet; T M Goodwin
Journal:  Am J Obstet Gynecol       Date:  1997-07       Impact factor: 8.661

Review 7.  Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies.

Authors:  Mark Alanis; Bradley S Hurst; Paul B Marshburn; Michelle L Matthews
Journal:  Fertil Steril       Date:  2006-09-27       Impact factor: 7.329

Review 8.  Placenta previa, placenta accreta, and vasa previa.

Authors:  Yinka Oyelese; John C Smulian
Journal:  Obstet Gynecol       Date:  2006-04       Impact factor: 7.661

9.  Conservative versus extirpative management in cases of placenta accreta.

Authors:  Gilles Kayem; Céline Davy; François Goffinet; Carole Thomas; Denis Clément; Dominique Cabrol
Journal:  Obstet Gynecol       Date:  2004-09       Impact factor: 7.661

10.  ACOG committee opinion. Placenta accreta. Number 266, January 2002. American College of Obstetricians and Gynecologists.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  2002-04       Impact factor: 3.561

View more
  18 in total

1.  Suspected invasive placenta: evaluation with magnetic resonance imaging.

Authors:  Laurence Bour; Vinciane Placé; Sandra Bendavid; Yann Fargeaudou; Jean-Jacques Portal; Aude Ricbourg; Delphine Sebbag; Anthony Dohan; Eric Vicaut; Philippe Soyer
Journal:  Eur Radiol       Date:  2014-07-29       Impact factor: 5.315

2.  Placenta previa percreta left in situ - management by delayed hysterectomy: a case report.

Authors:  Minna Tikkanen; Vedran Stefanovic; Jorma Paavonen
Journal:  J Med Case Rep       Date:  2011-08-25

Review 3.  Placenta accreta: diagnosis, management and the molecular biology of the morbidly adherent placenta.

Authors:  William A Goh; Ivica Zalud
Journal:  J Matern Fetal Neonatal Med       Date:  2015-07-27

4.  Evaluation of uterine artery recanalization and doppler parameters after bilateral uterine artery ligation in women with postpartum hemorrhage.

Authors:  Mustafa Kaplanoglu; Atilla Karateke; Burak Un; Levend Gunsoy; Ali Baloglu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

5.  Double-uterine-incision in the management of placenta previa complicated by placenta accreta spectrum.

Authors:  Zhengping Liu; Dazhi Fan; Dongxin Lin; Huishan Zhang; Jiaming Rao; Wen Wang; Shuzhen Wu; Yan Liu; Xiaoling Guo
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

6.  Epidemiology, etiology, diagnosis, and management of placenta accreta.

Authors:  Gali Garmi; Raed Salim
Journal:  Obstet Gynecol Int       Date:  2012-05-07

7.  What should we do to optimise outcome in twin pregnancy complicated with placenta percreta? A case report.

Authors:  Mehmet Aral Atalay; Fatma Oz Atalay; Bilge Cetinkaya Demir
Journal:  BMC Pregnancy Childbirth       Date:  2015-11-05       Impact factor: 3.007

8.  The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study.

Authors:  K E Fitzpatrick; S Sellers; P Spark; J J Kurinczuk; P Brocklehurst; M Knight
Journal:  BJOG       Date:  2013-08-07       Impact factor: 6.531

9.  Escalating placenta invasiveness: repeated placenta accreta at the limit of viability.

Authors:  Shirley Greenbaum; Alla Khashper; Elad Leron; Eric Ohana; Mihai Meirovitz; Reli Hershkovitz; Offer Erez
Journal:  Int J Womens Health       Date:  2016-04-15

10.  Clinical aspects and antenatal diagnosis of invasive placenta: a review of ten-years' experience of a multi-profile hospital in Lithuania.

Authors:  Jelena Volochovič; Diana Ramašauskaitė; Ramunė Šimkevičiūtė
Journal:  Acta Med Litu       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.